Peng Sida, Wang Jiani, Hu Pan, Zhang Wenhui, Li Huan, Xu Lihua
Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University Guangzhou 510230, P. R. China.
Cell Genetics Laboratory, The First Affiliated Hospital of Guangzhou Medical University Guangzhou 510230, P. R. China.
Int J Clin Exp Pathol. 2020 May 1;13(5):854-868. eCollection 2020.
Up-regulated expression of INHBA has been reported in multiple malignant tumors. However, in nasopharyngeal carcinoma (NPC), the expression pattern and clinical significance of INHBA are still unclear. This study aimed to detect the expression of INHBA and its prognostic significance in NPC, then explore the tumor-associated functions of INHBA gene and the potential mechanism. The expression of mRNA levels in tumor tissues and noncancerous nasopharyngeal tissues was investigated by RT-qPCR. The protein expression in cells were detected by western blot. Cell proliferation was detected by CCK assay and cell invasion ability was evaluated by Transwell assay. The expression of INHBA in paraffin-embedded NPC tissues was detected by immunohistochemistry (IHC). Statistical analyses were further applied to assess the clinical significance of INHBA expression. The result reveals mRNA level is elevated in NPC tissues compared to those in noncancerous nasopharyngeal epithelial tissues. In paraffin-embedded NPC tissues, immunoreactivity of INHBA was primarily detected in 53.70% (58/108) of these patients. The overexpression was notably associated with the clinical stage (UICC) (P=0.048), N classification (P=0.042), carotid sheath involvement (P=0.016), and decreased disease-free survival (DFS) (P=0.004) and overall survival (OS) (P=0.010). Multivariate analysis revealed that INHBA expression was an independent prognostic factor for DFS (P=0.028). CCK assay showed SUNE1 cells' proliferation was decreased in INHBA knockdown group than control. Transwell assay showed the invasion of SUNE1 cells was decreased in INHBA knockdown group by comparison with control. Further study showed knockdown of INHBA expression in SUNE1 cells could block the TGF-β signaling pathway. In conclusion, INHBA is up-regulated in NPC, and is significantly correlated with clinical stage (UICC), N stage, carotid sheath involvement, and survival. Knockdown INHBA in SUNE1 cells could inhibit the cells' proliferation and invasion. The underlying mechanism may be blockade of the TGF-β signaling pathway.
已有报道称,抑制素βA(INHBA)在多种恶性肿瘤中表达上调。然而,在鼻咽癌(NPC)中,INHBA的表达模式及临床意义仍不清楚。本研究旨在检测INHBA在NPC中的表达及其预后意义,进而探究INHBA基因的肿瘤相关功能及潜在机制。采用逆转录定量聚合酶链反应(RT-qPCR)检测肿瘤组织和鼻咽非癌组织中mRNA水平的表达。通过蛋白质免疫印迹法检测细胞中的蛋白质表达。采用细胞计数试剂盒(CCK)检测细胞增殖,并通过Transwell实验评估细胞侵袭能力。通过免疫组织化学(IHC)检测石蜡包埋的NPC组织中INHBA的表达。进一步应用统计学分析评估INHBA表达的临床意义。结果显示,与鼻咽非癌上皮组织相比,NPC组织中的mRNA水平升高。在石蜡包埋的NPC组织中,53.70%(58/108)的患者主要检测到INHBA的免疫反应性。其过表达与临床分期(国际抗癌联盟(UICC))显著相关(P = 0.048)、N分级(P = 0.042)、颈动脉鞘受累情况(P = 0.016),以及无病生存期(DFS)降低(P = 0.004)和总生存期(OS)降低(P = 0.010)。多因素分析显示,INHBA表达是DFS的独立预后因素(P = 0.028)。CCK实验显示,INHBA敲低组中SUNE1细胞的增殖较对照组降低。Transwell实验显示,与对照组相比,INHBA敲低组中SUNE1细胞的侵袭能力降低。进一步研究表明,敲低SUNE1细胞中INHBA的表达可阻断转化生长因子-β(TGF-β)信号通路。综上所述,INHBA在NPC中表达上调,且与临床分期(UICC)、N分期、颈动脉鞘受累情况及生存期显著相关。敲低SUNE1细胞中的INHBA可抑制细胞增殖和侵袭。潜在机制可能是阻断TGF-β信号通路。